-
Value proposition
Percutaneous ventricular reshaping system to treat patients with tricuspid regurgitation
Approxima is an early stage MedTech startup based in Milan, Italy. Our mission is to develop a percutaneous tricuspid valve repair system based on a right ventricular reshaping approach to treat patients with tricuspid regurgitation.
The company is conducting preclinical feasibility phase studies to demonstrate in-vivo feasibility, efficacy, and safety.
-
Home - Approxima
Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
https://www.approximamedical.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
La French Tech Italy
Government Administration (Auto), French Tech |
La French Tech Italy
Government Administration (Auto), French Tech |
Other
30 Nov 2024 |
|
|
Mazars
Consulting, audit, Accounting (Auto) |
Mazars
Consulting, audit, Accounting (Auto) |
Other
30 Nov 2024 |
|
|
Le Village by CA
Startup accelerator & VC, Business Consulting and Services (Auto) |
Le Village by CA
Startup accelerator & VC, Business Consulting and Services (Auto) |
Other
30 Nov 2024 |
|
|